Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Marco Cicardi, Aleena Banerji, Francisco Bracho, +57

New England Journal of Medicine

Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series

Murat Baş, Jens Greve, Klaus Stelter, +4

Annals of Emergency Medicine

Molecular PharmacologyMedicinal ChemistryMedicineVascular PharmacologyTherapeutic Efficacy +5

Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.

Vera Balz, Kathrin Scheckenbach, Karl Götte, +3

PubMed

MedicineP53 Inactivation FrequencyPathologyUnselected Tumor SpecimensP53 Inactivation +13

Mobile Health in Oncology: A Patient Survey About App-Assisted Cancer Care

Kerstin A. Kessel, Marco M. E. Vogel, Carmen Kessel, +11

JMIR mhealth and uhealth

Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy

Anja Müller, Enikö Sonkoly, Christine Eulert, +13

International Journal of Cancer

T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

Thomas K. Hoffmann, Christian Arsov, Kerstin Schirlau, +7

International Journal of Cancer

Squamous Cell CarcinomaImmunologyPathologyImmunodominanceAntigen Processing +19

Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck

H. Bier, Thomas K. Hoffmann, I. Haas, +1

Cancer Immunology Immunotherapy

Epidermal Growth FactorImmunologyHead And Neck CancerAntibody EngineeringReceptor Monoclonal Antibodies +8

Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis

Kathrin Scheckenbach, Oliver A. Cornely, Thomas K. Hoffmann, +6

Auris Nasus Larynx

Therapeutic OptionsTherapeutic EfficacyBiological TherapyClinical MycologyEndoscopic Sinus Surgery +3

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

H. Bier, Thomas K. Hoffmann, U. Häuser, +5

Cancer Chemotherapy and Pharmacology

MedicinePathologyHead And Neck CancerCancer TreatmentImmunotherapy +4

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients’ Attitude towards CAM in a University-Based Oncology Center in Germany

Kerstin A. Kessel, Sabrina Lettner, Carmen Kessel, +11

PLoS ONE